Revelation Biosciences (REVBW) Short Interest Ratio & Short Volume

Short interest is the volume of Revelation Biosciences shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 1,400 shares of REVBW short. Learn More on Revelation Biosciences' current short interest.

Revelation Biosciences saw a drop in short interest in July. As of July 15th, there was short interest totaling 1,400 shares, a drop of 50.0% from the previous total of 2,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Revelation Biosciences: Alvotech (0.07%), LAVA Therapeutics (0.13%), Mainz Biomed (8.71%), Pharvaris (0.76%), Procaps Group S.A. (0.11%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

Short selling REVBW is an investing strategy that aims to generate trading profit from Revelation Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Revelation Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REVBW, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REVBW, twice per month. The most recent reporting period available is July, 15 2024.